Alchimia

JUNE 20, 2016

A study published in February 2015 in the Pharmacology & Pharmacy journal showed that a CBD-rich extract from cannabis plants is much more efficient than CBD used in its pure form , mainly due the presence of other cannabinoids, terpenes and other molecules that greatly increase the dosage/efficiency ratio of CBD.

Medicine

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. Chronic migraines can make it incredibly challenging to hold down a job.

Terpenes

The Cannigma

JANUARY 24, 2022

They maximize the whole-plant entourage effect and provide the full terpene flavor profile of cannabis. Besides, most pens are made with distillate, which doesn’t provide the full range of cannabinoids and terpenes. The higher the temperature, the more destruction of terpenes and the production of harmful compounds.

Vaping

Greencamp

JANUARY 22, 2019

This function is best visible in the case of cancer and HIV/AIDS patients. In 2015, a study showed that patients who ingested cannabis had much lower viral loads from patients who didn’t use it. ( HIV patients participating in this study had higher CD4-cell numbers. References. Hermanson and Lawrence J.

Cannabinoids

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction

Greencamp

DECEMBER 4, 2018

This is why CBD works wonders for anxiety ( 4 ) and also PTSD patients. Dustin Sulak who is one of the top-tier cannabis physicians in the US and has extensive experience with treating patients with medical cannabis. Cannabis for PTSD: Latest Scientific Evidence Shows Promising Results. References.

Cannabinoids

SpeedWeed

JULY 19, 2021

Phytol is a terpene that’s sometimes used to add flavor to vape cartridges, usually by adding it to a mix of cannabis oil and the common thinning agent propylene glycol. The AIA request had been requested by David Heldreth , the former chief science officer of True Terpenes, a major phytol reseller. David Downs/Leafly).

Vaping

Greencamp

DECEMBER 25, 2018

Also, strains high in terpene called pinene are known to cause less damage to short-term memory. Exclusive bonus : Download a free dosage guide that will show you the exact step-by-step process Dr. Dustin Sulak used to successfully treat more than 18,000 patients with cannabis. Find the right strain for you. Get Started.

Research and Development

The Cannigma

DECEMBER 12, 2022

Using integration or psychotherapy along with these medicines allows patients to incorporate the positive effects permanently. It became illegal in the US in 2009. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder.

History

Cannabis Law Report

OCTOBER 29, 2019

Routine nonsteroidal anti-inflammatory drug (NSAID) treatments, though efficacious, may not provide adequate relief of pain due to osteoarthritis (OA) and might have potential side effects that preclude its use, particularly in geriatric patients with certain comorbidities, such as kidney or gastrointestinal pathologies ( 1 – 4 ).

Safety

Cannabis Law Report

JUNE 4, 2021

Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers.

Research and Development